Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
3.970
-0.010 (-0.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
Senti Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -70.9 | -71.06 | -58.21 | -55.32 | -19.86 | -21.16 |
| Depreciation & Amortization | 5.87 | 5.43 | 3.92 | 3.01 | 1.99 | 1.4 |
| Loss (Gain) From Sale of Assets | 0.11 | -21.86 | - | - | - | - |
| Asset Writedown & Restructuring Costs | 0.58 | 25.96 | - | 0.02 | 0.24 | 0.01 |
| Loss (Gain) From Sale of Investments | - | -1.07 | -0.36 | - | -0 | -0.29 |
| Stock-Based Compensation | 3.21 | 9.67 | 16.39 | 2.3 | 0.27 | 0.21 |
| Other Operating Activities | 14.71 | -4.13 | -10.55 | 14.74 | -5.03 | - |
| Change in Accounts Receivable | 0.98 | -0.93 | -0.13 | -0.4 | -0.01 | 0.12 |
| Change in Accounts Payable | -1.2 | -0.29 | 0.19 | -0.62 | -0.32 | 0.63 |
| Change in Unearned Revenue | -0.41 | -0.11 | -1.03 | 1.83 | 0.17 | - |
| Change in Other Net Operating Assets | 12.11 | 5.99 | 14.88 | -0.21 | -1.61 | 0.71 |
| Operating Cash Flow | -34.93 | -52.4 | -34.9 | -34.64 | -24.17 | -18.38 |
| Capital Expenditures | -0.02 | -12.04 | -41.37 | -5.54 | -1.16 | -2 |
| Sale of Property, Plant & Equipment | 0.17 | 0.11 | - | - | - | 0.02 |
| Investment in Securities | - | 42.01 | -40.59 | - | 12.52 | 5.73 |
| Investing Cash Flow | 0.15 | 30.08 | -81.96 | -5.54 | 11.36 | 3.75 |
| Short-Term Debt Issued | - | - | - | - | 8 | - |
| Long-Term Debt Issued | - | - | 117.15 | - | - | - |
| Total Debt Issued | - | - | 117.15 | - | 8 | - |
| Long-Term Debt Repaid | - | -0.11 | - | -0.02 | - | - |
| Net Debt Issued (Repaid) | -0.02 | -0.11 | 117.15 | -0.02 | 8 | - |
| Issuance of Common Stock | 0.59 | 0.89 | 1.4 | 1.5 | 0.33 | 0.02 |
| Other Financing Activities | 2.43 | - | - | - | -0.28 | -0.02 |
| Financing Cash Flow | 3 | 0.78 | 118.55 | 68.44 | 38.05 | 14.01 |
| Net Cash Flow | -31.79 | -21.54 | 1.7 | 28.26 | 25.24 | -0.62 |
| Free Cash Flow | -34.95 | -64.43 | -76.27 | -40.18 | -25.33 | -20.37 |
| Free Cash Flow Margin | - | -2515.93% | -1779.51% | -1455.20% | -4475.97% | -23969.41% |
| Free Cash Flow Per Share | -7.69 | -14.52 | -29.21 | -137.96 | -18.28 | -15.00 |
| Levered Free Cash Flow | 2.95 | -75.14 | -57.23 | -17.92 | -14.27 | - |
| Unlevered Free Cash Flow | 2.95 | -75.14 | -57.23 | -17.92 | -14.27 | - |
| Change in Net Working Capital | -29.42 | 39.95 | -3.46 | -7.6 | -0.06 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.